Article info

Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials

Authors

  1. Correspondence to Professor Mona Abdel-Tawab, Central Laboratory of German Pharmacists, Eschborn 65760, Germany; m.tawab{at}zentrallabor.com
View Full Text

Citation

Abdel-Tawab M, Waßmuth M, Gegenfurtner F, et al
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials

Publication history

  • Received February 11, 2022
  • Accepted June 21, 2022
  • First published July 19, 2022.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.